News Release

share on google plus
Text size
view with small font size
view with medium font size
view with large font size

Kyowa Hakko News Releases 1999

November 1, 1999
Fancl succeeded in launching a new hair-growing agent, a quasi-drug “Medicated Mohkatsurin PB”, from collaboration with Kyowa Hakko
September 20, 1999
Phase Ⅱ clinical study of an antiparkinson agent started in the USA
September 13, 1999
Publishing a Booklet “Health, Safety, and the Environment” (in Japanese and English)
Environment- and Safety-Related Cost and Volume of Emissions Having the Environmental Impact Shown in Actual Figures
September 3, 1999
Establishment of a Venture Company on the Analysis of functional genomics of human
August 31, 1999
Mitsubishi Chemical Corporation / Kyowa Hakko Kogyo Co., Ltd.
To Establish a Joint Venture for Plasticizers Business
August 19, 1999
Launching “Form Up® Doucé -GM”,
A New Amino Acid Surfactant of Low Irritability
August 4, 1999
Raw Material for Cosmetics with Skin Whitening Effect
Market Launching of “Sodium L-Ascorbyl-L-Phosphate”
June 22, 1999
Complete genome sequence of Corynebacterium glutamicum
almost determined
May 10, 1999
Launch of “Navelbine”, an anticancer agent
to be used in the treatment of non-small cell lung cancer
March 18, 1999
Kyowa Medex Co., Ltd. has concluded a license agreement
to introduce diagnostic kits for Alzheimer's Disease
from Synapse Technologies Inc. in Canada
March 15, 1999
“Vinorelbine Tartrate”
NDA approval of A New Anticanser Drug
February 25, 1999
Kyowa Medex Co., Ltd.
has concluded an agreement to supply
Sanofi Diagnostics Pasteur with a fully automated
device for microplate enzymatic immunoassay


To Page Top

Return to Top